Nippon India Pharma Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹208 Cr | ₹8689 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.35 | 1.81 |
| Manager | Rohan Korde | Sailesh Raj Bhan |
| ISIN Code | INF00XX01BL5 | INF204K01968 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | 3.47% | 3.03% |
| 6 Month | 20.7% | 13.37% |
| 1 Year | 43.48% | 36.31% |
| 3 Year | 20.61% | 20.52% |
| 5 Year | - | 27.7% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 37.03% | 26.5% |
| 3 Year | 32% | 30.42% |
| 5 Year | - | 25.06% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 20.74% | 17.79% |
| 3 Year | 19.19% | 20.87% |
| 5 Year | - | 20.18% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 14.52% | 14.36% |
| Sharp | - | 0.68% |
| Beta | - | 0.91% |
| Alpha | - | 1.57% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Rohan Korde | Sailesh Raj Bhan |
| Total AUM | ₹4626 Cr | ₹96086 Cr |
| Fund Manage | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.8 | 4.4 |
| Large Cap | 38.11 | 45.96 |
| Mid Cap | 26.43 | 27.12 |
| Small Cap | 33.66 | 22.52 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.8 | 4.4 |
| Pharmaceuticals & Biotechnology | 77 | 75.86 |
| Healthcare Services | 18.01 | 17.38 |
| Chemicals & Petrochemicals | 0.96 | - |
| Fertilizers & Agrochemicals | 1.03 | - |
| Insurance | 1.2 | - |
| Retailing | - | 2.36 |
Top Comparisons
Tata Gold ETF Fund of Fund - Regular (G)
3Y Returns0%
Mirae Asset Nifty India Manufacturing ETF FOF - Regular Plan - Growth
3Y Returns0%
Nippon India Vision Fund-Growth Plan-Growth Option
3Y Returns20.85%
HSBC Large & Mid Cap Fund - Regular Growth
3Y Returns21.52%
Mahindra Manulife Dynamic Bond Fund - Regular Plan - Growth
3Y Returns4.81%
UTI Dynamic Bond Fund - Regular Plan - Growth Option
3Y Returns8.14%
ITI Arbitrage Fund Regular - Growth
3Y Returns5.28%
Mirae Asset Arbitrage Fund Regular Growth
3Y Returns6.16%